FOXE1 and cancer: Although expressions of 9 hyper-methylated genes were significantly different across cancer stages in the TCGA cohort, reduced expressions with increased cancer severity were observed for 3 hyper-methylated genes- SLITRK3, FOXE1, and TWIST1 (Fig. 2D).